Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-22T07:30:38.842Z Has data issue: false hasContentIssue false
  • English
  • Français

Specificities of Treatment in Pediatric Obsessive-Compulsive Disorder

Published online by Cambridge University Press:  07 November 2014

Martine F. Flament ,
Dan Geller ,
Metehan Irak  and
Pierre Blier
Get access Rights & Permissions [Opens in a new window]

Abstract

Obsessive-compulsive disorder (OCD) experienced in childhood or adolescence is often a chronic disorder with high subjective distress and impairment of family and social functioning. An early comprehensive intervention schedule can have a profound effect on outcome in later years. The clinical manifestations of OCD among children and adolescents do not seem to be inherently different from those of adult patients. In younger subjects, the clinical picture tends to be dominated by compulsions, and insight can be poor, with little recognition of the symptoms as a problem.There is often a shift in symptoms over time, with some symptoms being replaced by others, while in adults, the core obsessions and compulsions tend to be more stable. In addition to depression and anxiety disorders, the spectrum of comorbid psychopathology seen in pediatric OCD patients includes tic, disruptive behavior, and specific developmental disorders. The treatment of childhood and adolescent OCD relies on cognitive-behavioral techniques of psychotherapy and pharmacotherapeutic interventions similar to those recommended in adults. The efficacy of exposure and response prevention in pediatric OCD has been shown in numerous open studies, and four controlled trials. Pharmacotherapy relies on serotonergic medication, and all have been demonstrated to be significantly superior to placebo, as reported in a recently published meta-analysis. Current concerns with the use of SSRIs in children and adolescents were explored as regards OCD and anxiety disorders, and there is no evidence for an increase in suicide or related behaviors.

Type
Supplements
Information
CNS Spectrums , Volume 12 , supplement S3: From Obsessive-Compulsive Spectrum to Obsessive-Compulsive Disorders: The Cape Town Consensus Statement , February 2007 , pp. 43 - 58
Copyright
Copyright © Cambridge University Press 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Pauls, D, Alsobrook, J, Goodman, W, Rasmussen, S, Leckman, J. A family study of obsessive-compulsive disorder. Am J Psychiatry. 1995;(152):76–84.Google ScholarPubMed
2. Murphy, TK, Voeller, KS, Blier, P. Neurobiology of obsessive-compulsive disorder. In: Martin, A, Scahill, L, Charney, DS, Leckman, JF, eds. Pediatric Psychopharmacology. Oxford: Oxford University Press; 2003:150–163.Google Scholar
3 Geller, DA, Biederman, J, Stewart, SE, et al. Which SSRI? a meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am J Psychiatry 2003a;160(11):1919–1928.CrossRefGoogle ScholarPubMed
4. Swedo, SE, Rapoport, JL, Leonard, H, Lenane, M, Cheslow, D. Obsessive-compulsive disorder in children and adolescents. Clinical phenomenology of 70 consecutive cases. Arch Gen Psychiatry. 1989;46(4):335–341.CrossRefGoogle ScholarPubMed
5. Flament, MF, Koby, E, Rapoport, JL, et al. Childhood obsessive-compulsive disorder: a prospective follow-up study. J Chid Psychol Psychiatry. 1990;31(3):363–380.CrossRefGoogle ScholarPubMed
6. Hanna, GL. Demographic and clinical features of obsessive-compulsive disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1995;34:19–27.CrossRefGoogle ScholarPubMed
7. Riddle, MA, Scahill, L, King, R, et al. Obsessive compulsive disorder in children and adolescents: phenomenology and family history. J Am Acad Child Adolesc Psychiatry. 1990;29:766–772.CrossRefGoogle ScholarPubMed
8. Honjo, S, Hirano, C, Murase, S, et al. Obsessive-Compulsive Symptoms in Childhood and Adolescence. Acta psychiatrica Scandinavica 1989;80(1):83–91.CrossRefGoogle ScholarPubMed
9. Khanna, S. and Srinath, S. Childhood obsessive-compulsive disorder. 1. Psychopathology. Psychopathology 1989;32:47–54.Google Scholar
10. Apter, A, Tyano, S. Obsessive compulsive disorders in adolescence. J Adolesc. 1988;11(3):183–194.CrossRefGoogle ScholarPubMed
11. Thomsen, PH. Obsessive-compulsive symptoms in children and adolescents. A phenomenological analysis of 61 Danish cases. Psychopathology. 1991;24(1):12–18.CrossRefGoogle ScholarPubMed
12. Toro, J, Cervera, M, Osejo, E, Salamero, M. Obsessive-compulsive disorder in childhood and adolescence: a clinical study. Journal of child psychology and psychiatry, and allied disciplines. 1992;33(6):1025–1037.CrossRefGoogle ScholarPubMed
13. Cohen, DJ, Leckman, JF. Developmental psychopathology and neurobiology of Tourette's syndrome. J Am Acad Child Adolesc Psychiatry. 1994;33:2–15.CrossRefGoogle ScholarPubMed
14. Flament, MF, Whitaker, A, Rapoport, JL, et al. Obsessive compulsive disorder in adolescence: an epidemiological study. J Am Acad.Child Adolesc Psychiatry. 1988;27(6):764–771.CrossRefGoogle ScholarPubMed
15. Rettew, DC, Swedo, SE, Leonard, HL, Lenane, MC, Rapoport, JL. Obsessions and compulsions across time in 79 children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 1992;31(6): 1050–1056.CrossRefGoogle ScholarPubMed
16. Pollock, R, Carter, A. The familial and developmental context of obsessive-compulsive disorder. Child Adolesc Psychiatr Clin North Am. 1999;8:461–479.CrossRefGoogle ScholarPubMed
17. Leonard, HL, Goldberger, EL, Rapoport, JL, et al. Childhood rituals: normal development or obsessive-compulsive symptoms? J Am Acad Child Adolesc Psychiatry. 1990;29:17–23.CrossRefGoogle ScholarPubMed
18. Rasmussen, SA, Tsuang, MT. Clinical characteristics and family history in DSM-III obsessive-compulsive disorder. Am J Psychiatry. 1986;143:317–322.Google ScholarPubMed
19. Flament, MF, Cohen, D. Child and adolescent obsessive-compulsive disorder: a review. In: Maj, M, Sartorius, N, Okasha, A, Zohar, J, eds. Obsessive-Compulsive Disorder: WPA Series Evidence and Experience in Psychiatry. Vol 4, 2nd ed. Chichester: John Wiley & Sons; 2002:147–183.CrossRefGoogle Scholar
20. Heyman, I, Fombonne, E, Simmons, H, Ford, T, Meltzer, H, Goodman, R. Prevalence of obsessive-compulsive disorder in the British Nationwide Survey of Child Mental Health. Br J Psychiatry. 2001;179:324–329.CrossRefGoogle ScholarPubMed
21. March, JS, Franklin, M, Nelson, A, Foa, E. Cognitive-behavioral psychotherapy for pediatric obsessive-compulsive disorder. J Clin Child Psychol. 2001;30(1):8–18.CrossRefGoogle ScholarPubMed
22. Franklin, ME, Foa, EB. Cognitive-behavioral treatments for obsessive compulsive disorder. In: Nathan, PE, Gorman, JM, eds. A Guide to Treatments that Work. New York, NY: Oxford University Press; 1998:339–357.Google Scholar
23. March, JS, Mulle, K. OCD in Children and Adolescents: A Cognitive-Behavioral Treatment Manual. New York, NY: Guilford Press; 1998.Google Scholar
24. Bolton, D, Collins, S, Steinberg, D. The treatment of obsessive-compulsive disorder in adolescence. A report of fifteen cases. Br J Psychiatry. 1983;142:456–464.CrossRefGoogle ScholarPubMed
25. Bolton, D, Luckie, M, Steinberg, D. Long-term course of obsessive-compulsive disorder treated in adolescence. J Am Acad Child Adolesc Psychiatry. 1995;34(11):1441–1450.CrossRefGoogle ScholarPubMed
26. March, JS, Mulle, K, Herbel, B. Behavioral psychotherapy for children and adolescents with obsessive-compulsive disorder: an open trial of a new protocol-driven treatment package. J Am Acad Child Adolesc Psychiatry. 1994;33(3):333–441.CrossRefGoogle ScholarPubMed
27. Scahill, L, Vitulano, LA, Brenner, EM, Lynch, KA, King, RA. Behavioral therapy in children and adolescents with obsessive-compulsive disorder: a pilot study. J Child Adolesc Psychopharmacol. 1996:6(3):191–202.CrossRefGoogle ScholarPubMed
28. Wever, C, Rey, JM. Juvenile obsessive-compulsive disorder. Aust N Z J Psychiatry. 1997:31(1):105–113.CrossRefGoogle ScholarPubMed
29. Fischer, DJ, Himle, JA, Hanna, GL. Group behavioral therapy for adolescents with obsessive-compulsive disorder: preliminary outcomes. Res Soc Work Pract. 1998;8:629–636.CrossRefGoogle Scholar
30. Thienemann, M, Martin, J, Cregger, B, Thompson, HB, Dyer-Friedman, J. Manual-driven group cognitive-behavioral therapy for adolescents with obsessive-compulsive disorder: a pilot study. J Am Acad Child Adolesc Psychiatry. 2001;40(11): 1254–1260.CrossRefGoogle ScholarPubMed
31. Waters, TL, Barret, PM, March, JS. Cognitive-behavioral family treatment of chilhood obsessive-compulsive disorder: preliminary findings. Am J Psychother. 2001;55(3):372–387.CrossRefGoogle Scholar
32. Benazon, NR, Ager, J, Rosenberg, DR. Cognitive behavior therapy in treatment-naive children and adolescents with obsessive-compulsive disorder: an open trial. Behav Res Ther. 2002;40:529–539.CrossRefGoogle ScholarPubMed
33. Piacentini, J, Bergman, RL, Courney, J, McCracken, JT, Kretchman, J. Open trial of cognitive behavior therapy for chilhood obsessive-compulsive disorder. J Anxiety Dis. 2002;16:207–219.CrossRefGoogle Scholar
34. Barrett, PM, Healy-Farrell, L, March, JS. Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial. J Am Acad Child Adolesc Psychiatry. 2004;43(1):46–62.CrossRefGoogle ScholarPubMed
35. Barrett, P, Farrell, L, Dadds, M, Boulter, N. Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: long-term follow-up and predictors of outcome.2005;44(10):1005–1014.Google ScholarPubMed
36. De Haan, E, Hoogduin, KA, Buitleaar, JK, Keijsers, GP. Behavior therapy versus clomipramine for the treatment of obsessive-compulsive disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1998;37(10):1022–1029.CrossRefGoogle ScholarPubMed
37. Franklin, ME, Foa, EB, March, JS. The pediatric obsessive-compulsive disorder treatment study: Rationale, design and methods. J Am Acad Child Adolesc Psychiatry. 2003;13(suppl 1):S39–S51.Google ScholarPubMed
38. Pediatric OCDTreatment Study(POTS) Team. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA. 2004;292(16):1969–1976.CrossRefGoogle Scholar
39. Asbahr, FR, Castillo, AR, Ito, LM, Latorre, MR, Moreira, MN, Lotufo-Neto, F. Group cognitive-behavioral therapy versus sertraline for the treatment of children and adolescents with osessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 2005;44(11): 1128–1136.CrossRefGoogle ScholarPubMed
40. Franklin, ME, Kozak, MJ, Cashman, LA, Coles, ME, Rheingold, AA, Foa, EB. Cognitive-behavioral treatment of pediatric obsessive-compulsive disorder: an open clinical trial. J Am Acad Child Adolesc Psychiatry. 1998;37(4):412–419.CrossRefGoogle ScholarPubMed
41. Kobak, KA, Greist, JH, Jefferson, JW, Katzelnick, DJ, Henk, HJ. Behavioral versus pharmacological treatments of obsessive compulsive disorder: A meta-analysis. Psychopharmacology 1998;136:205–216.CrossRefGoogle ScholarPubMed
42. Flament, MF, Rapoport, JL, Kilts, C. A controlled trial of clomipramine in childhood obsessive compulsive disorder. Psychopharmacol Bull. 1985;21(1): 150–152.Google ScholarPubMed
43. Leonard, HL, Swedo, SE, Rapoport, JL, et al. Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind cross-over comparison. Arch Gen Psychiatry. 1989;46(12):1088–1092.CrossRefGoogle Scholar
44. DeVeaugh-Geiss, J, Moroz, G, Biederman, J, et al. Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder–a multicenter trial. J Am Acad Child Adolesc Psychiatry. 1992;31(1):45–49.CrossRefGoogle ScholarPubMed
45. Riddle, MA, Scahill, L, King, RA, et al. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 1992;31(6):1062–1069.CrossRefGoogle ScholarPubMed
46. Thomsen, PH. Child and adolescent obsessive-compulsive disorder treated with citalopram: findings from an open trial of 23 cases. J Child Adolesc Psychopharmacol. 1997;7(3):157–166.CrossRefGoogle ScholarPubMed
47. Riddle, MA, Reeve, EA, Yaryura-Tobias, JA, et al. Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial. J Am Acad Child Adolesc Psychiatry. 2001;40(2):222–229.CrossRefGoogle ScholarPubMed
48. Geller, DA, Hoog, SL, Heiligenstein, JH, et al. Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial. J Am Acad Child Adolesc Psychiatry. 2001;40(7):773–779.CrossRefGoogle ScholarPubMed
49. Liebowitz, MR, Turner, SM, Piacentini, J, et al. Fluoxetine in children and adolescents with OCD: a placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 2002;41(12):1431–1438.CrossRefGoogle ScholarPubMed
50. Geller, DA, Wagner, KD, Emsile, G, et al. Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 2004;43(11):1387–1396.CrossRefGoogle ScholarPubMed
51. March, JS, Biederman, J, Wolkow, R, et al. Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial. JAMA 1998;280(20):1752–1756.CrossRefGoogle ScholarPubMed
52. Alderman, J, Wolkow, R, Chung, M, Johnston, HF. Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression: pharmacokinetics, tolerability, and efficacy. J Am Acad Child Adolesc Psychiatry. 1998;37(4):386–394.CrossRefGoogle ScholarPubMed
53. Flament, MF, Cohen, D. Emotional regulation and affective disorders in children and adolescents with obsessive compulsive disorder. In: Nadel, J, Muir, D. Emotional Development. New York, NY: Oxford University Press: 2005:383–408.Google Scholar
54. Blier, P, Saint-Andre, E, Hebert, C, de Montigny, C, Lavoie, N, Debonnel, G. Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers. Int J Neuropsychopharmacol. 2006;10(1):41–50.CrossRefGoogle ScholarPubMed
55. Bergeron, R, Blier, P. Cisapride for the treatment of nausea produced by selective serotonin reuptake inhibitors. Am J Psychiatry. 1994;151(7):1084–1086.Google ScholarPubMed
56. Leonard, HL, Meyer, MC, Swedo, SE, et al. Electrocardiographic changes during desipramine and clomipramine treatment in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1995;34(11):1460–1468.CrossRefGoogle ScholarPubMed
57. Pigott, TA, Seay, S. Biological treatments for obsessive-compulsive disorder. In: Swinson, RP, Antony, MM, Rachman, S, Richter, MM. Obsessive-Compulsive Disorder: Theory, Research and Treatment. New York, NY: The Guilford Press: 2001:298–326.Google Scholar
58. Varley, CK. Sudden death related to selected tricyclic antidepressants in children: epidemiology, mechanisms and clinical implications. Pediatric Drugs. 2001;3(8):613–627.CrossRefGoogle ScholarPubMed
59. Hammerness, PG, Vivas, FM, Geller, DA. Selective serotonin reuptake in pediatric psychopharmacology: a review of the evidence. J Pediatr. 2006: 148(2):158–165.CrossRefGoogle ScholarPubMed
60. Scharko, AM. Selective serotonin reuptake inhibitor-induced sexual dysfunction in adolescents: a review. J Am Acad Child Adolesc Psychiatry. 2004;43(9):1071–1079.CrossRefGoogle ScholarPubMed
61. Nilsson, O, Jakobsen, AM, Kolby, L, Bernhardt, R Forssell-Aronsson, E, Ahlman, H. Importance of vesicle proteins in the diagnosis and treatment of neuroendocrine tumors. Ann N Y Acad Sci. 2004;1014:280–283.Google Scholar
62. Weintrob, N, Cohen, D, Klipper-Aurbach, Y, Zadik, Z, Dickerman, Z. Decreased growth during therapy with selective serotonin reuptake inhibitors. Arch Pediatrics Adolesc Med. 2002;156(7):696–701.CrossRefGoogle ScholarPubMed
63. Fergusson, D, Doucette, S, Glass, KG, et al. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. BMJ 2005;19(330):653–659.Google Scholar
64. Hammad, TA, Laughren, T, Racoosin, J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry. 2006;63(3):332–339.CrossRefGoogle ScholarPubMed
65. Whittington, CJ, Kendall, T, Fonagy, P Cornell, D, Cotgrove, A, Boddington, E. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet. 2004;363(94181:1341–1345.CrossRefGoogle ScholarPubMed
66. Sallinen, BJ, Nangle, DW, O'Grady, AC. Case study: successful medication withdrawal using cognitive-behavioral therapy for a preadolescent with OCD. J Am Acad Child Adolesc Psychiatry. 2004;43(11):1441–1444.CrossRefGoogle ScholarPubMed
67. Storch, EA, Murphy, TK, Geffken, GR, et al. Cognitive-behavioral therapy for PANDAS-related obsessive-compulsive disorder: Findings from a preliminary waitlist controlled open trial. J Am Acad Child Adolesc Psychiatry. 2006;45(10):1171–1178.CrossRefGoogle ScholarPubMed
68. Flament, MF, Chabane, N. Obsessive-compulsive disorder and tics in children and adolescents. In: Gelder, M, Lopez-Ibor, JJ, Andreasen, NC, eds. The New Oxford Textbook of Psychiatry. Oxford: Oxford University Press: 2000:1771–1781.Google Scholar
69. Geller, DA, Biederman, J, Stewart, SE, et al. Impact of comorbidity on treatment response to proxetine in pediatric obsessive-compulsive disorder: Is the use of exclusion criteria empirically supported in randomized clinicaltrials? J Child Adolesc Psychopharmacol. 2003b:13(Suppl 1):S19–S29.CrossRefGoogle Scholar
70. Geller, DA, Biederman, J, Jones, J, et al. Is juvenile obsessive-compulsive disorder a developmental subtype of the disorder? A review of the pediatric literature. J Am Acad Child Adolesc Psychiatry. 1998;37(4):420–427.CrossRefGoogle ScholarPubMed
71. Leonard, HL, Swedo, SE, Lenane, MC, et al. A 2- to 7-year follow-up study of 54 obsessive-compulsive children and adolescents. Arch Gen Psychiatry. 1993:50(6):429–439.CrossRefGoogle ScholarPubMed
72. Wewetzer, C, Jans, T, Muller, B, et al. Long-term outcome and prognosis of obsessive-compulsive disorder with onset in childhood or adolescence. Eur Child Adolesc Psychiatry. 2001;10(1):37–46.CrossRefGoogle ScholarPubMed
73. Zohar, AH, Ratzosin, G, Pauls, DL, et al. An epidemiological study of obsessive-compulsive disorder and related disorders in Israeli adolescents. J Am Acad Child Adolesc Psychiatry. 1992; 31:1057–1061.CrossRefGoogle ScholarPubMed
74. Leonard, HL, Lenane, M, Swedo, SE, Rettew, DC, Gerrshon, ES, Rapoport, JL. Tics and Tourette's disorder: A 2-to 7-year follow-up of 54 obsessive-compulsive children. Am J Psychiatry. 1992;149:1244–1251.Google Scholar
75. Leckman, JF. Tourette's syndrome. In: Hollander, E. Obsessive-Compulsive Related Disorders. Washington, DC: American Psychiatric Publishing Inc.: 1993:113–138.Google Scholar
76. Pauls, DL, Raymond, CL, Leckman, JF, Stevenson, JM. A family study of Tourette's syndrom. Am J Hum Genet. 1991;48:154–163.Google Scholar
77. Kurlan, R, Como, PG, Deeley, C, McDermott, M, McDermott, MP. A pilot controlled study of fluoxetine for obsessive-compulsive symptoms in children with Tourette's syndrome. Clin Neuropsychopharmacol. 1993:16(2):167–172.CrossRefGoogle ScholarPubMed
78. Delgado, PL, Goodman, WK, Price, LH, Heninger, GR, Charney, DS. Fluvoxamine/pimozide treatment of concurrent tourette's and obsessive-compulsive disorder. Br J Psychiatry. 1990;157:762–765.CrossRefGoogle ScholarPubMed
79. Fennig, S, Fennig, SN, Pato, M, Weitzman, A. Emergence of symptoms of Tourette's syndrome during fluvoxamine treatment of obsessive-compulsive disorder. Br J Psychiatry. 1994:164(6):839–841.CrossRefGoogle ScholarPubMed
80. Reinblatt, S, Walkup, JT. Psychopharmacologic treatment of pediatric anxiety disorders. Child Adolesc Psychiatr Clin North Am. 2005;14:877–908.CrossRefGoogle ScholarPubMed
81. Fitzgerald, KD, MacMaster, FP, Paulson, LD, Rosenberg, DR. Neurobiology of childhood obsessive-compulsive disorder. Child Adolesc Psychiatr Clin N Am. 1999;8(3):533–575.CrossRefGoogle ScholarPubMed
82. Geller, DA, Biederman, J, Griffin, S, Jones, J, Lefkowitz, TR. Comorbidity of obsessive-compulsive disorder with disruptive behavior disorders. J Am Acad Child Adolesc Psychiatry. 1996;35:1637–1646.CrossRefGoogle ScholarPubMed
83. AACAP. Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 1998;37(10):27S–45S.CrossRefGoogle Scholar
84. Grados, M, Scahill, L, Riddle, MA. Pharmacotherapy in children and adolescents with obsessive-compulsive disorder. Child Adolesc Psychiatr Clin N Am. 1999:8(3):617–634.CrossRefGoogle ScholarPubMed
85. DeVane, CL. Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors. Cellular and Molecular Biology. 1999;19(4):443–466.Google ScholarPubMed
86. Mork, A, Kreilgaard, M, Sanchez, C. The r-Enantiomer of citalopram counteracts escitalo-pram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats. Neuropharmacology. 2003;45(2):167–173.CrossRefGoogle ScholarPubMed
87. El Mansari, M, Sanchez, C, Chouvet, G, Renaud, B, Haddjeri, N. Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: an id vivo electrophysiological study in rat brain. Neuropsychopharmacology. 2005;30(7):1269–1277.CrossRefGoogle Scholar
88. Gorman, JM, Korotzer, A, Su, G. Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: pooled analysis of placebo-controlled trials. CNS Spectr. 2002;4(suppl 1):40–44.CrossRefGoogle Scholar
89. Chen, F, Larsen, MB, Sanchez, C, Wiborg, O. The s-enantiomer of r, s-citalopram increases inhibitor binding to the human serotonin transporter inhibitors. Eur Nuempsychopharmacol. 2005;15:193–198.CrossRefGoogle Scholar
90. Mellerup, ET, Plenge, P. Why some depressed patients may have low platelet 3H-imipramine binding. Acta psychiatr Scand. 1990;82(4):330–334.CrossRefGoogle ScholarPubMed
91. Leonard, HL, Topol, D, Bukstein, O, Hindmarsh, D, Allen, AJ, Swedo, SE. Clonazepam as an augmenting agent in the treatment of childhood-onset obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 1994;33(6):792–794.CrossRefGoogle ScholarPubMed
92. Simeon, JG, Thatte, S, Wiggins, D. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination. Psychopharmacology Bull. 1990;26(3):285–290.Google ScholarPubMed
93. Figueroa, Y, Rosenberg, DR, Birmaher, B, Keshavan, MS. Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents. J Child Adolesc Psychopharmacol. 1998;8(1):61–67.CrossRefGoogle ScholarPubMed
94. Thomsen, PH. Risperidone augmentation in the treatment of severe adolescent OCD in SSRI-refractory cases: a case-series. Ann Clin Psychiatry. 2004;16(4):201–207.CrossRefGoogle ScholarPubMed
95. Fux, M, Levine, J, Aviv, A, Belmaker, RH. Inositol treatment of obsessive-compulsive disorder. Am J Psychiatry. 1996;153(9):1219–1221.Google ScholarPubMed
96. Dannon, PN, Sasson, Y, Hirschmann, S, lancu, I, Grunhaus, LJ, Zohar, J. Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial. Eur Neuropsychopharmacol. 2000;10(3):165–169.CrossRefGoogle ScholarPubMed
97. Neziroglu, F, Yaryura-Tobias, JA, Walz, J, McKay, D. The effect of fluvoxamine and behavior therapy on children and adolescents with obsessive-compulsive disorder. J Child Adolesc Psychopharmacol. 2000;10(4):295–306.CrossRefGoogle ScholarPubMed
98. Cook, EH, Wagner, KD, March, JS, et al. Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 2001;40(10):1751–1181.CrossRefGoogle ScholarPubMed
99. Thomsen, PH, Ebbesen, C, Persson, C. Long-term experience with citalopram in the treatment of adolescent OCD. J Am Acad Child Adolesc Psychiatry. 2001;40(8):895–902.CrossRefGoogle ScholarPubMed
100. Leonard, HL, Swedo, SE, Lenane, MC, et al. A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder. Arch Gen Psychiatry. 1991;48:922–927.CrossRefGoogle ScholarPubMed
101. Greist, JH, Bandelow, B, Hollander, E, et al. WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adults. CNS Spectr. 2003;8(Suppl 8):7–16.CrossRefGoogle ScholarPubMed
102. Baldwin, DS, Montgomery, SA, Nil, R, Lader, M. Discontinuation symptoms in depression and anxiety disorders. Int J Neuropsychopharmacol. 2005;19:1–12.Google Scholar
103. Stewart, SE, Geller, DA, Jenike, M, et al. Long-term outcome of pediatric obsessive-compulsive disorder: a meta-analysis and qualitative review of the literature. Acta psychiatr Scand. 2004;110(1):4–13.CrossRefGoogle ScholarPubMed
104. Swedo, SE, Leonard, H, Shapiro, MB, et al. Sydenham's chorea: physical and psychological symptoms of saint vitus dance. Pediatrics. 1993;91:706–713.Google Scholar
105. Asbahr, FR, Negrao, AB, Gentil, V, et al. Obsessive-compulsive and related symptoms in children and adolescents with rheumatic fever with and without chorea: a prospective 6-month study. Am J Psychiatry. 1998;(155):1122–1124.Google Scholar
106. Swedo, S, Leonard, HL, Garvey, M, et al. Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections (PANDAS): clinical description of the first 50 cases. Am J Psychiatry. 1998;155(2):264–271.CrossRefGoogle ScholarPubMed
107. Perlmutter, SJ, Leitman, SF, Garvey, MA, et al. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorders in childhood. Lancet. 1999;354:1153–1158.CrossRefGoogle ScholarPubMed
108. Garvey, MA, Perlmutter, SJ, Allen, AJ, et al. A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry. 1999;45:1564–1571.CrossRefGoogle ScholarPubMed
109. Nicolson, R, Swedo, SE, Lenane, M, et al. An open trial of plasma exchange in childhood-onset obsessive-compulsive disorder without poststreptococcal exacerbations. J Am Acad Child Adolesc Psychiatry. 2000;39(10):1313–1315.CrossRefGoogle ScholarPubMed
110. Snider, LA, Lougee, L, Slattery, M, Grant, P, Swedo, SE. Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders. Biol Psychiatry. 2005;57(7):788–792.CrossRefGoogle ScholarPubMed
111. Storch, EA, Murphy, TK, Geffken, GR, Star, J, Goodman, WK. Behavioral treatment of child with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection. J Am Acad Child Adolesc Psychiatry. 2004;43(5):510–511.CrossRefGoogle Scholar
112. Apter, A, Bernhout, E, Tyano, S. Severe obsessive compulsive disorder in adolescence: a report of eight cases. J Aldolesc. 1984;7(4):349–358.CrossRefGoogle ScholarPubMed
113. Target, M, Fonagy, P. Efficacy of psychoanalysis for children with emotional disorders. J Am Acad Child Adolesc Psychiatry. 1994;33(3):361–371.CrossRefGoogle ScholarPubMed
114. Lenane, M. Families in obsessive-compulsive disorder. In: Rapoport, JL. Obsessive-Compulsive Disorder in Children and Adolescents. Washington, DC: American Psychiatric Press: 1989:237–249.Google Scholar
115. Lenane, M. Family therapy for children with obsessive-compulsive disorder. In: Pato, MT, Zohar, M. Current Treatments of Obsessive Compulsive Disorder - Clinical Practice. Washington, DC: American Psychiatric Association Press: 1991:103–113.Google Scholar
116. March, JS, Frances, A, Carpenter, D, Kahn, DA. The Expert Guideline Series: Treatment of Obsessive-Compulsive Disorder. J Clin Psychiatry. 1997:58(Suppl 4):1–72.Google Scholar
117. Owens, MJ, Morgan, WN, Plott, SJ, Nemeroff, CB. Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J Pharmacol Exp Ther. 1997;283(3):1305–1322.Google ScholarPubMed
118. Jeppesen, U, Loft, S, Poulsen, HE, Bersen, K. A fluvoxamine-caffeine interaction study. Pharmacogenetics. 1996;6(31):213–222.CrossRefGoogle ScholarPubMed
119. Sayal, KS, Duncan-McConnell, DA, McConnell, HW, Taylor, DM. Psychotropic interactions with warfarin. Acta psychiatr Scand. 2000; 102(4):250–255.CrossRefGoogle ScholarPubMed